These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12411222)

  • 21. Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder.
    Steiner M; Brown E; Trzepacz P; Dillon J; Berger C; Carter D; Reid R; Stewart D
    Arch Womens Ment Health; 2003 Feb; 6(1):71-7. PubMed ID: 12715267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
    Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
    N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premenstrual syndrome no progesterone; premenstrual dysphoric disorder no serotonin deficiency.
    van Leusden HA
    Lancet; 1995 Dec; 346(8988):1443-4. PubMed ID: 7490987
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of premenstrual dysphoric disorder with the GABA
    Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
    Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoxetine in the treatment of premenstrual dysphoric disorder.
    Carr RR; Ensom MH
    Ann Pharmacother; 2002 Apr; 36(4):713-7. PubMed ID: 11918525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.
    Steiner M
    J Psychiatry Neurosci; 2000 Nov; 25(5):459-68. PubMed ID: 11109297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.
    Jermain DM; Preece CK; Sykes RL; Kuehl TJ; Sulak PJ
    Arch Fam Med; 1999; 8(4):328-32. PubMed ID: 10418540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
    Med Lett Drugs Ther; 2001 Jan; 43(1096):5-6. PubMed ID: 11177220
    [No Abstract]   [Full Text] [Related]  

  • 29. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M; Xiao S
    Am J Psychiatry; 2004 Feb; 161(2):343-51. PubMed ID: 14754784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial.
    Sundblad C; Modigh K; Andersch B; Eriksson E
    Acta Psychiatr Scand; 1992 Jan; 85(1):39-47. PubMed ID: 1546547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria.
    Steiner M; Korzekwa M; Lamont J; Wilkins A
    Psychopharmacol Bull; 1997; 33(4):771-4. PubMed ID: 9493491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications.
    Parry BL
    CNS Drugs; 2001; 15(4):277-85. PubMed ID: 11463133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder.
    Pearlstein T; Yonkers KA; Fayyad R; Gillespie JA
    J Affect Disord; 2005 Apr; 85(3):275-82. PubMed ID: 15780697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.
    Bixo M; Allard P; Bäckström T; Mjörndal T; Nyberg S; Spigset O; Sundström-Poromaa I
    Psychoneuroendocrinology; 2001 Aug; 26(6):551-64. PubMed ID: 11403977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressants in the treatment of premenstrual dysphoric disorder.
    Yonkers KA
    J Clin Psychiatry; 1997; 58 Suppl 14():4-10; discussion 11-3. PubMed ID: 9418742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The measurement of premenstrual mood symptoms.
    Steiner M; Streiner DL; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D
    J Affect Disord; 1999 Jun; 53(3):269-73. PubMed ID: 10404713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of fluoxetine in the treatment of premenstrual dysphoric disorder.
    Romano S; Judge R; Dillon J; Shuler C; Sundell K
    Clin Ther; 1999 Apr; 21(4):615-33; discussion 613. PubMed ID: 10363729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoxetine's spectrum of action in premenstrual syndrome.
    Menkes DB; Taghavi E; Mason PA; Howard RC
    Int Clin Psychopharmacol; 1993; 8(2):95-102. PubMed ID: 8345163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.
    Young SA; Hurt PH; Benedek DM; Howard RS
    J Clin Psychiatry; 1998 Feb; 59(2):76-80. PubMed ID: 9501889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder.
    FitzGerald M; Malone KM; Li S; Harrison WM; McBride PA; Endicott J; Cooper T; Mann JJ
    Am J Psychiatry; 1997 Apr; 154(4):556-8. PubMed ID: 9090347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.